Eagle Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-7.00525.9515.1315.5318.6557.7352.36-77.0310.60N/A11.4557.73
Price/Sales ratio
6.5920.416.503.402.784.213.343.871.19N/A1.284.21
Price/Book Value ratio
3.8014.968.144.503.704.613.373.761.61N/A1.744.61
Price/Cash Flow ratio
-9.09-139.1423.1613.6911.3514.7612.6823.557.45N/A8.0514.76
Price/Free Cash Flow ratio
-9.06-116.5837.9015.0111.3814.9612.8723.827.48N/A8.0814.96
Price/Earnings Growth ratio
-0.03-4.800.00-0.45-0.50-1.11-3.630.44-0.02N/A0.02-0.50
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
38.66%76.37%70.81%75.84%70.97%68.91%75.79%75.41%70.01%N/A70.01%68.91%
Operating Profit Margin
-98.20%3.86%28.15%31.25%17.16%11.13%13.44%-1.69%25.57%N/A25.57%17.16%
Pretax Profit Margin
-100.90%3.88%28.19%30.81%15.95%11.22%12.07%-2.65%19.40%N/A19.40%15.95%
Net Profit Margin
-94.12%3.88%42.98%21.94%14.95%7.30%6.38%-5.02%11.25%N/A11.25%11.25%
Effective Tax Rate
6.71%0.11%-52.45%28.79%6.27%34.93%47.13%-89.68%41.98%N/A41.98%6.27%
Return on Assets
-33.65%2.06%38.13%19.23%13.37%5.62%4.73%-3.40%8.77%N/A8.77%8.77%
Return On Equity
-54.31%2.84%53.86%28.99%19.84%7.98%6.44%-4.88%15.26%N/A15.50%15.50%
Return on Capital Employed
-56.67%2.83%30.77%33.21%18.40%10.11%11.74%-1.62%27.43%N/A27.43%18.40%
Liquidity Ratios
Current Ratio
2.603.562.663.984.124.624.36N/AN/AN/A1.694.62
Quick Ratio
2.543.122.643.883.914.454.142.021.26N/A1.154.45
Cash ratio
1.112.301.312.421.982.822.701.310.49N/A0.492.82
Days of Sales Outstanding
139.43144.7681.2782.99113.7689.4499.3487.5584.66N/A83.5189.44
Days of Inventory outstanding
40.32350.8818.0732.6648.9539.3564.82189.57183.75N/A183.7548.95
Operating Cycle
179.75495.6599.35115.65162.71128.79164.17277.13268.41N/A204.34162.71
Days of Payables Outstanding
126.4789.9797.1276.4758.4632.7350.32142.1873.02N/A73.0258.46
Cash Conversion Cycle
53.27405.682.2339.18104.2596.06113.85134.94195.39N/A55.7996.06
Debt Ratios
Debt Ratio
N/AN/AN/A0.170.180.150.130.100.15N/A0.420.18
Debt Equity Ratio
N/AN/AN/A0.260.270.210.170.140.26N/A0.730.27
Long-term Debt to Capitalization
N/AN/AN/A0.190.190.150.11N/A0.19N/A0.190.19
Total Debt to Capitalization
N/AN/AN/A0.210.210.170.150.120.21N/A0.210.21
Interest Coverage Ratio
-2.34K232.726.45K66.4516.988.1212.78N/AN/AN/A18.0316.98
Cash Flow to Debt Ratio
N/AN/AN/A1.231.171.451.491.100.81N/A0.811.45
Company Equity Multiplier
1.611.371.411.501.481.421.361.431.73N/A1.731.48
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.72-0.140.280.240.240.280.260.160.16N/A0.160.28
Free Cash Flow / Operating Cash Flow Ratio
1.001.190.610.910.990.980.980.980.9910.990.99
Cash Flow Coverage Ratio
N/AN/AN/A1.231.171.451.491.100.81N/A0.811.45
Short Term Coverage Ratio
N/AN/AN/A12.088.3811.196.181.108.11N/A8.1111.19
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A